Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59), packaged ...
FDA Drug Recall #D-0057-2018 — Class III — September 25, 2017
Recall Summary
| Recall Number | D-0057-2018 |
| Classification | Class III — Low risk |
| Date Initiated | September 25, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Precision Dose Inc. |
| Location | South Beloit, IL |
| Product Type | Drugs |
| Quantity | 801 cases |
Product Description
Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59), packaged in 10-count cups per tray, 3 trays per case containing a total of 5 mL x 30 Unit Dose Cups per case (NDC 68094-301-62), Rx only, Pkg: Precision Dose, Inc., S. Beloit, IL 61080.
Reason for Recall
Subpotent Drug: low out of specification results.
Distribution Pattern
Nationwide in the USA
Lot / Code Information
Lot number: 500105, Exp 04/30/18
Other Recalls from Precision Dose Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0095-2022 | Class II | Acetaminophen Oral Suspension, 325 mg/10.15 mL,... | Nov 1, 2021 |
| D-0094-2022 | Class II | Acetaminophen Oral Suspension, 160 mg/5 mL, pac... | Nov 1, 2021 |
| D-0228-2021 | Class II | Chlorhexidine Gluconate Oral Rinse USP 0.12%, p... | Jan 1, 2021 |
| D-1004-2020 | Class II | Ranitidine Oral Solution, USP, 150 mg/10 mL, [1... | Nov 13, 2019 |
| D-1037-2017 | Class II | Carbamazepine Oral Suspension, USP. 100 mg/5 mL... | Jul 5, 2017 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.